Dr. Starpoli's Blog

Incisionless Anti-reflux Therapy: a chance to stop your reflux drugs.

Posted by Anthony A. Starpoli, MD on Jun 5, 2019 10:54:02 AM

Gastroesophageal Reflux Disease (GERD) is a life-affecting condition that affects as many as 20% of the population. Given the prevalence of GERD, the quest for suitable treatment methods has been a relentless one— but often to little effect.

Read More

Anthony A. Starpoli, MD | www.starpoli.com

Obesity, Reflux, fundoplication, atypical reflux, heartburn, EsophyX, incisionless surgery, GERD Awareness Week

EsophyX TIF Procedure is Superior to Maximum Dose PPI Therapy

Posted by Anthony Starpoli on May 30, 2013 12:30:00 AM

As reported by Medscape, according to research presented at the Digestive Disease Week meeting, “patients with gastroesophageal reflux disease (GERD) might benefit more from transoral incisionless fundoplication (TIF) than from continued treatment with proton-pump inhibitors (PPIs).” The study’s lead author Karim Trad, MD, said, “In this study, transoral incisionless fundoplication was superior to maximal-dose PPIs in eliminating daily troublesome typical and atypical symptoms in selected patients.” Dr. Trad added that the findings “establish for the first time that, for some patients, the procedure is better than maximal-dose PPI therapy for controlling a range of GERD symptoms.”

Read More

Anthony A. Starpoli, MD | www.starpoli.com

hiatal hernia, fundoplication, LINX, GERD, atypical reflux, EsophyX, incisionless surgery, esophageal cancer

Hybrid GERD Surgery Performed at NYU Langone Medical Center

Posted by Anthony Starpoli on Oct 14, 2011 11:40:00 AM

On September 7th and October 13th, 2011, the first two combined laparoscopic and transoral antireflux procedures were performed at the New York Univerisity Langone Medical Center in New York City.

Read More

Anthony A. Starpoli, MD | www.starpoli.com

Reflux, hiatal hernia, TIF, fundoplication, GERD, LPR, atypical reflux, heartburn, EsophyX, Barrett's Esophagus

Antireflux Surgery and GERD Drug Therapy Achieve Similar Results

Posted by Anthony Starpoli on Jun 4, 2011 11:43:00 AM


 
A report was published in the May 18 issue ofA report was published in the May 18 issue of Journal of the American Medical Association. In, what is referred to as the LOTUS (Long-Term Usage of Esomeprazole vs Surgery for Treatment of Chronic GERD) study, remission rates at five years were 92% (95% CI 89 to 96) for patients on esomeprazole and 85% (95% CI 81 to 90, P=0.048) for those who had laparoscopic antireflux surgery, according to Jean-Paul Galmiche, MD, of Nantes University in France, and colleagues. 

Read More

Anthony A. Starpoli, MD | www.starpoli.com

Reflux, TIF, fundoplication, GERD, nonacid reflux, EsophyX